Developer docs
API playgroundTry for free, no card

Search company profiles

IndieBio

Full company profile

uuid02m5oyn

Namestring
IndieBio
Legal namestring
SOSV LLC
Websiteurl
indiebio.co
Company typeenum
Private
Founded yearint
2015
Descriptiontext

IndieBio is a startup accelerator program operated by SOSV LLC, a venture capital firm. Founded in San Francisco in 2015, it was Silicon Valley's first biotech program to combine on-site bio-labs with pre-seed investment for scientist-founders ready to launch companies. The program subsequently expanded its footprint to include a second location in New York City and extended its mandate from biotechnology into broader deep tech categories, including chemistry, physics, and AI. Its portfolio spans food, agriculture, industrial decarbonization, AI, therapeutics, and diagnostics.

The program's core offering pairs physical wet-lab infrastructure with pre-seed capital and accelerator services for early-stage science entrepreneurs. Between 2015 and 2025, IndieBio supported 310 graduate companies, which collectively raised $3.6 billion in follow-on funding across various stages. At the start of 2026, SOSV rebranded the IndieBio brand to SOSV SF (San Francisco) and SOSV NY (New York City) to reflect the broadened deep tech scope, while retaining the same teams, locations, and facilities. The IndieBio trademark remains held by SOSV LLC.

As a program of a private VC parent, IndieBio does not disclose standalone revenue or pricing; economics for the broader SOSV accelerator system typically derive from fund management fees and equity participation in portfolio companies. The company is privately held with no public listing, and no independent equity holders or minority investors in the IndieBio brand are disclosed in the source material.

Short descriptiontext

IndieBio is a deep tech startup accelerator operated by SOSV LLC, founded in 2015 in San Francisco, offering on-site bio-labs and pre-seed investment to scientist-founders. The program rebranded in 2026 to SOSV SF and SOSV NY to reflect its expanded scope beyond biotech into all deep tech sectors.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
Markets served

Serves global market

Keyword5 values
biotech accelerator programs, pre-seed startup funding, venture capital incubation, deep tech investment, startup laboratory access
Industry2 codes
1Corporate Accelerators & Startup Programs
CodeFSANAHADPrimaryYes
2Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling)
CodeHLAAAJAFPrimaryNo
NAICS code1 code
  • Educational Support Services611710
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Startup Accelerator Programs
No data
Cost components5 values
Personnel, Infrastructure, Operations, Marketing or Sales, Technology or R&D
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 2 records shown
1SOSV SF
Description

Rebranded from IndieBio San Francisco in 2026; deep tech accelerator program operated by SOSV LLC in San Francisco, covering bio, chemistry, physics, AI, and other deep tech sectors.

indiebio.co
+1 more record
Core offering1 text field

IndieBio is a startup accelerator program operated by SOSV LLC that provides scientist-founders with on-site bio-laboratory facilities combined with pre-seed capital investment to launch biotech and deep tech companies. Founded in 2015 in San Francisco as Silicon Valley's first biotech program with on-site bio-labs and pre-seed funding, the program supported 310 graduate companies that collectively raised $3.6 billion between 2015 and 2025. In early 2026 it was rebranded to SOSV SF and SOSV NY to reflect an expanded mandate covering all deep tech including chemistry, physics, AI, and biotechnology.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

IndieBio was a single unified accelerator program — Silicon Valley’s first biotech program to offer bio-labs on site as well as pre-seed investment to scientists ready to launch startups. Between 2015 and 2025, its 310 graduates raised $3.6 billion. At the start of 2026, the program was rebranded to SOSV NY (New York City) and SOSV SF (San Francisco) to capture the program's expanded remit beyond biotech into all deep tech fields including chemistry, physics, and AI.

Product and service1 record
1IndieBio Accelerator Program
CategoryStartup Accelerator Program
Description

A cohort-based biotech and deep tech startup accelerator program that provides scientist-founders with on-site bio-laboratory facilities, pre-seed capital, and mentorship in exchange for equity in their companies. Designed for pre-seed stage founders working in biotechnology, chemistry, physics, AI, food, agriculture, industrial decarbonization, therapeutics, and diagnostics. In 2026 the program was rebranded to SOSV SF and SOSV NY under parent SOSV LLC to reflect its expanded mandate beyond biotechnology into all of deep tech.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
1Petri
TypeEmerging player
Description

Petri is an emerging biotech-specific accelerator providing pre-seed funding and resources to early-stage life science startups, representing a more focused emerging competitor to IndieBio in the biotech acceleration niche.

TypeDirect peer
Description

Techstars is a global accelerator network offering mentorship-driven programs with equity investment, including specific biotech and healthcare verticals that compete head-to-head with IndieBio for early-stage life science startups.

TypeEmerging player
Description

Bolt is a hardware and deep tech accelerator providing pre-seed investment and prototyping infrastructure, comparable to IndieBio's lab-backed, infrastructure-heavy deep tech acceleration model.

TypeRegional player
Description

BioGenerator is a St. Louis-based biotech startup accelerator and investor providing pre-seed capital and lab resources to life science founders, operating a comparable model to IndieBio but focused on the St. Louis regional ecosystem.

TypeDirect peer
Description

Y Combinator is the largest global startup accelerator and has built out a dedicated bio track offering pre-seed investment and lab partnerships to scientist-founders, directly competing for the same biotech startup deal flow as IndieBio.

TypeRegional player
Description

Creative Destruction Lab is a science-based startup accelerator operating across multiple geographies including Canada, US, and Europe, supporting founders in biotech, energy, and deep tech with a program model comparable to IndieBio.

TypeEmerging player
Description

Entrepreneur First is a global deep tech talent investor that helps scientists and engineers build companies from scratch, operating a similar pre-seed, founder-first model with global cohorts.

TypeDirect peer
Description

Plug and Play is a global innovation platform and accelerator running multiple verticals including health and biotech, competing with IndieBio for early-stage biotech and health-tech founders through corporate partnership programs.

TypeBroad incumbent
Description

Flagship Pioneering is a large, established biotech venture creation firm that originates and funds breakthrough life science companies — a broader incumbent operating upstream in the biotech funnel that overlaps with IndieBio's biotech deal flow.

TypeEmerging player
Description

2048 Ventures is an early-stage venture firm backing technical founders in deep tech, AI, and frontier science — operating in adjacent deep tech pre-seed territory and competing for similar founder talent.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses2 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

IndieBio

Startup Accelerator Programsindiebio.co

IndieBio is a deep tech startup accelerator operated by SOSV LLC, founded in 2015 in San Francisco, offering on-site bio-labs and pre-seed investment to scientist-founders. The program rebranded in 2026 to SOSV SF and SOSV NY to reflect its expanded scope beyond biotech into all deep tech sectors.

What IndieBio does

IndieBio is a startup accelerator program operated by SOSV LLC, a venture capital firm. Founded in San Francisco in 2015, it was Silicon Valley's first biotech program to combine on-site bio-labs with pre-seed investment for scientist-founders ready to launch companies. The program subsequently expanded its footprint to include a second location in New York City and extended its mandate from biotechnology into broader deep tech categories, including chemistry, physics, and AI. Its portfolio spans food, agriculture, industrial decarbonization, AI, therapeutics, and diagnostics.

The program's core offering pairs physical wet-lab infrastructure with pre-seed capital and accelerator services for early-stage science entrepreneurs. Between 2015 and 2025, IndieBio supported 310 graduate companies, which collectively raised $3.6 billion in follow-on funding across various stages. At the start of 2026, SOSV rebranded the IndieBio brand to SOSV SF (San Francisco) and SOSV NY (New York City) to reflect the broadened deep tech scope, while retaining the same teams, locations, and facilities. The IndieBio trademark remains held by SOSV LLC.

As a program of a private VC parent, IndieBio does not disclose standalone revenue or pricing; economics for the broader SOSV accelerator system typically derive from fund management fees and equity participation in portfolio companies. The company is privately held with no public listing, and no independent equity holders or minority investors in the IndieBio brand are disclosed in the source material.

IndieBio firmographics

Firmographics
Name
IndieBio
Legal name
SOSV LLC
Website
https://indiebio.co
Company type
Private
Founded year
2015
Operating status
Operating
Short description
IndieBio is a deep tech startup accelerator operated by SOSV LLC, founded in 2015 in San Francisco, offering on-site bio-labs and pre-seed investment to scientist-founders. The program rebranded in 2026 to SOSV SF and SOSV NY to reflect its expanded scope beyond biotech into all deep tech sectors.
Ownership category
akta.pro rank

IndieBio industry classification

Industry
Product category
Startup Accelerator Programs
NAICS
Educational Support Services (611710)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry
Corporate Accelerators & Startup Programs (FSANAHAD)
akta.pro secondary industry
Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling) (HLAAAJAF)

Keywords

  • Biotech accelerator programs
  • Pre-seed startup funding
  • Venture capital incubation
  • Deep tech investment
  • Startup laboratory access

IndieBio business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Infrastructure, Operations, Marketing or Sales, Technology or R&D

IndieBio product offering

Product offering

Core offering

IndieBio is a startup accelerator program operated by SOSV LLC that provides scientist-founders with on-site bio-laboratory facilities combined with pre-seed capital investment to launch biotech and deep tech companies. Founded in 2015 in San Francisco as Silicon Valley's first biotech program with on-site bio-labs and pre-seed funding, the program supported 310 graduate companies that collectively raised $3.6 billion between 2015 and 2025. In early 2026 it was rebranded to SOSV SF and SOSV NY to reflect an expanded mandate covering all deep tech including chemistry, physics, AI, and biotechnology.

Product overview

IndieBio was a single unified accelerator program — Silicon Valley’s first biotech program to offer bio-labs on site as well as pre-seed investment to scientists ready to launch startups. Between 2015 and 2025, its 310 graduates raised $3.6 billion. At the start of 2026, the program was rebranded to SOSV NY (New York City) and SOSV SF (San Francisco) to capture the program's expanded remit beyond biotech into all deep tech fields including chemistry, physics, and AI.

Differentiator

Problem solved

Functional benefit

Brands

  • SOSV SF: Rebranded from IndieBio San Francisco in 2026; deep tech accelerator program operated by SOSV LLC in San Francisco, covering bio, chemistry, physics, AI, and other deep tech sectors.
  • SOSV NY

Products and services

  • IndieBio Accelerator Program A cohort-based biotech and deep tech startup accelerator program that provides scientist-founders with on-site bio-laboratory facilities, pre-seed capital, and mentorship in exchange for equity in their companies. Designed for pre-seed stage founders working in biotechnology, chemistry, physics, AI, food, agriculture, industrial decarbonization, therapeutics, and diagnostics. In 2026 the program was rebranded to SOSV SF and SOSV NY under parent SOSV LLC to reflect its expanded mandate beyond biotechnology into all of deep tech.

Companies that use IndieBio

Customer profile

Segments1 record

Ideal customer profiles1 record

IndieBio technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

IndieBio partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves4 records

Expansion highlights3 records

IndieBio competitors and assessment

Company assessment

Emerging players

  • Petri: Petri is an emerging biotech-specific accelerator providing pre-seed funding and resources to early-stage life science startups, representing a more focused emerging competitor to IndieBio in the biotech acceleration niche.
  • Bolt: Bolt is a hardware and deep tech accelerator providing pre-seed investment and prototyping infrastructure, comparable to IndieBio's lab-backed, infrastructure-heavy deep tech acceleration model.
  • Entrepreneur First: Entrepreneur First is a global deep tech talent investor that helps scientists and engineers build companies from scratch, operating a similar pre-seed, founder-first model with global cohorts.
  • 2048 Ventures: 2048 Ventures is an early-stage venture firm backing technical founders in deep tech, AI, and frontier science — operating in adjacent deep tech pre-seed territory and competing for similar founder talent.

Direct peers

  • Techstars: Techstars is a global accelerator network offering mentorship-driven programs with equity investment, including specific biotech and healthcare verticals that compete head-to-head with IndieBio for early-stage life science startups.
  • Y Combinator: Y Combinator is the largest global startup accelerator and has built out a dedicated bio track offering pre-seed investment and lab partnerships to scientist-founders, directly competing for the same biotech startup deal flow as IndieBio.
  • Plug and Play Tech Center: Plug and Play is a global innovation platform and accelerator running multiple verticals including health and biotech, competing with IndieBio for early-stage biotech and health-tech founders through corporate partnership programs.

Regional players

  • BioGenerator: BioGenerator is a St. Louis-based biotech startup accelerator and investor providing pre-seed capital and lab resources to life science founders, operating a comparable model to IndieBio but focused on the St. Louis regional ecosystem.
  • Creative Destruction Lab: Creative Destruction Lab is a science-based startup accelerator operating across multiple geographies including Canada, US, and Europe, supporting founders in biotech, energy, and deep tech with a program model comparable to IndieBio.

Broad incumbents

  • Flagship Pioneering: Flagship Pioneering is a large, established biotech venture creation firm that originates and funds breakthrough life science companies — a broader incumbent operating upstream in the biotech funnel that overlaps with IndieBio's biotech deal flow.

Market position

Strengths4 records

Weaknesses2 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

IndieBio financial estimates

Financial estimate

Revenue estimate

Valuation estimate

IndieBio leadership team

Management profile

Number of profiles

IndieBio funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

IndieBio M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IndieBio

What does IndieBio do?

IndieBio is a startup accelerator program operated by SOSV LLC that provides scientist-founders with on-site bio-laboratory facilities combined with pre-seed capital investment to launch biotech and deep tech companies. Founded in 2015 in San Francisco as Silicon Valley's first biotech program with on-site bio-labs and pre-seed funding, the program supported 310 graduate companies that collectively raised $3.6 billion between 2015 and 2025. In early 2026 it was rebranded to SOSV SF and SOSV NY to reflect an expanded mandate covering all deep tech including chemistry, physics, AI, and biotechnology.

Is IndieBio a public or private company?

IndieBio is a private company. It is classified as corporate owned and is currently operating.

When was IndieBio founded?

IndieBio was founded in 2015.

Who are IndieBio's main competitors?

Emerging players on record are Petri, Bolt, Entrepreneur First and 2048 Ventures. Direct peers are Techstars, Y Combinator and Plug and Play Tech Center. Regional players are BioGenerator and Creative Destruction Lab. Flagship Pioneering is listed as a broad incumbent.

Does IndieBio have an API?

No public API is recorded for IndieBio.

What industry is IndieBio in?

IndieBio's product category is Startup Accelerator Programs. Its primary akta.pro industry code is FSANAHAD, Corporate Accelerators & Startup Programs, with a secondary code of HLAAAJAF, Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling). Its NAICS code is 611710 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
SosvIndieBio New York 2026 Investor ShowcaseIndieBio New York's March 11 Investor Showcase features 20 biotech companies across AI, bioscience, and therapeutics. Companies include Primary Bioscience, Materia Bioworks, and HexemBio, with funding details and product descriptions. The showcase aims to attract investors to these startups.Business InsiderWe tasted the first lab-grown sausage made without slaughtering any animals — here's what it was likeSilicon Valley startup New Age Meats conducted the first public tasting of a lab-grown pork sausage made from animal cells without slaughtering animals, serving the product to journalists and prospective investors at a San Francisco brewery on Monday. The startup, founded two months prior with $250,000 in seed funding from biotech accelerator IndieBio, produced the sausage using fat and muscle cells from a live pig. The company acknowledges significant challenges ahead, including reducing high production costs—similar to the $330,000 first lab-grown beef burger in 2013—and replacing fetal bovine serum with slaughter-free alternatives before commercial viability, which several industry CEOs estimate is at least five to 10 years away.SynBioBetaSOSV's IndieBio and Genome Project-Write partner to fund and advise startupsSOSV's IndieBio and the Genome Project-write consortium have partnered to launch the GP-write Startup Team, which will vet, fund, and advise early-stage startups focused on genome engineering technologies. Selected ventures will join IndieBio's September 2022 cohort to receive mentorship, laboratory access, and pre-seed investment of up to $500,000. The initiative aims to accelerate advances in synthetic biology by bridging academic innovation with commercial development.NyBuilding Bridges: Puerto Rico Startups Connect with New York's Life Science EcosystemThirteen life science entrepreneurs from Puerto Rico participated in a two-day networking event at IndieBio NY, facilitated by New York's Empire State Development as part of Governor Kathy Hochul's Life Science Exchange Initiative with Puerto Rico. The visit followed an earlier entrepreneurial bootcamp in San Juan and aimed to connect Puerto Rican startups with New York’s biotech investors, industry leaders, and research institutions. This collaboration seeks to accelerate innovation and economic development within the life science sectors of both regions.World-CollectiveFunding Opportunities for Sustainable Textile StartupsThe article provides a comprehensive guide to over ten funding opportunities, including grants and accelerators, specifically designed for sustainable textile startups. It highlights key programs such as Fashion for Good, H&M Foundation’s Global Change Award, and IndieBio, while outlining the financial barriers these companies face in scaling eco-friendly innovations.PeonyTop 10 Biotech Startup Accelerators in 2025The article presents a curated list of the top 10 biotech startup accelerators for 2025, highlighting programs such as IndieBio, Johnson & Johnson Innovation – JLABS, and StartX Med. It details their investment models, facility offerings, and strategic advantages to help founders navigate high development costs and regulatory timelines.PapermarkTop 10 Biotech Startup Accelerators in 2025This article presents a curated list of the top 10 biotech startup accelerators for 2025, detailing their investment sizes, program lengths, and specific focus areas such as genomics and synthetic biology. It provides strategic guidance for founders on selecting appropriate programs and optimizing pitch deck distribution using the Papermark platform. The content highlights key industry players like IndieBio, JLABS by Johnson & Johnson Innovation, and Illumina to illustrate the landscape of support available for early-stage life sciences ventures.IndiebioSóliome: Creating the World’s Best SunscreenSóliome, a startup backed by IndieBio, is developing a new sunscreen based on protein chemistry biomimicry to address consumer demand for safer, more effective products. The company claims its active ingredient withstands continuous UV exposure without needing frequent reapplication and aligns with regulatory trends in regions like Hawaii, Europe, and Korea banning harmful chemical filters.LinkedInCompanies - IndieBio - #1 in Early Stage BiotechTastee Tape is currently participating in the IndieBio NY program as part of Class 8, a period the founder describes as transformative. The company plans to share key learnings from this experience in future posts while continuing to build and grow in New York City. This content serves as a personal update on the startup's incubation journey rather than a report on specific business metrics or external events.LinkedInRybodyn - IndieBio SF Demo Day 15RyboDyn Inc. graduated from the IndieBio/SOSV SF program (batch 15) following a Demo Day in San Francisco last week. The company is developing immunotherapies by targeting the dark proteome to create new treatments for cancer and autoimmune diseases. Their strategy involves using an in-house platform for lead discovery to deliver first-in-class assets for solid tumors.